Global Health & Biotech Archives | Page 3 of 285 | Be Korea-savvy

Archive by category Global Health & Biotech

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs  Teva’s first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth Strategy Rise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact [...]

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

VANCOUVER, British Columbia, Nov. 18, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer. Mr. Platshon will report directly to Zymeworks’ Chair and Chief Executive Officer, Kenneth [...]

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholders Strategic initiative follows positive topline results from pivotal Phase 3 HERIZON-GEA-01 trial evaluating zanidatamab in first-line gastroesophageal adenocarcinoma (GEA) and pasritamig advancing to registration studies by J&J Innovative Medicine (J&J) Eligible to receive up to $440.0 million in potential [...]

Philips brings AI into the procedure room to assist doctors during heart valve repair

Philips brings AI into the procedure room to assist doctors during heart valve repair

November 17, 2025 Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one [...]

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Biopharma will continue to lead discovery and new product development  Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium International headquarters remain in Paris, France, while the United States headquarters are in St Louis, Missouri ST. LOUIS, Nov. 17, 2025 (Korea Bizwire) – Curium, a company dedicated [...]

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal

Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim analysis Ziihera plus Tevimbra® (tislelizumab) and chemotherapy demonstrated clinically meaningful and statistically significant improvements in OS and PFS versus trastuzumab and [...]

Positioning Barbados as the Caribbean’s Life Sciences Hub

Positioning Barbados as the Caribbean’s Life Sciences Hub

EarlyHealth City to Anchor US$200 Million Investment BRIDGETOWN, Barbados, Nov. 14, 2025 (Korea Bizwire) – Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world-class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church. The [...]

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

New York, NY and Woburn, MA, Nov. 10, 2025 (Korea Bizwire) – Azurity Pharmaceuticals names Ogilvy Health as public relations and marketing agency of record. Ogilvy Health’s mandate will focus on reimagining Azurity’s brand story centered on patient commitment and pioneering growth. The agency will also enhance Azurity’s external visibility – both online and offline [...]

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO XR Most (85%) participants taking AUSTEDO or AUSTEDO XR in conjunction with their mental health medications reported that their mental health condition [...]

Carestream to Showcase Award-Winning Innovation and New Products at RSNA 2025

Carestream to Showcase Award-Winning Innovation and New Products at RSNA 2025

Rochester, N.Y., Nov. 05, 2025 (Korea Bizwire) – Carestream Health is excited to showcase the award-winning, customer-first solutions behind its versatile portfolio of X-ray imaging solutions at the Radiologic Society of North America (RSNA) Annual Conference from November 30-December 4, 2025, in Chicago. Attendees can visit Booth #2154 in the South Hall to learn how [...]